Skip to content
Governance Register

← US public companies

Starr Kevin P

SEC-identified person · CIK 1192603 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Sage Therapeutics, Inc. SAGE Director filed 2014–2023
Jounce Therapeutics, Inc. JNCE Officer filed 2017–2021
Fulcrum Therapeutics, Inc. FULC Officer filed 2019–2021
Revolution Medicines, Inc. RVMD Officer filed 2020–2021
Nurix Therapeutics, Inc. NRIX Officer filed 2020–2021
Decibel Therapeutics, Inc. [DBTX] Officer filed 2021–2021
Relay Therapeutics, Inc. RLAY Officer filed 2020–2021
Pliant Therapeutics, INC. PLRX Officer filed 2020–2020
Voyager Therapeutics, Inc. VYGR Officer filed 2015–2018
Rhythm Pharmaceuticals, INC. SRYTM Officer filed 2017–2018
Constellation Pharmaceuticals INC CNST Officer filed 2018–2018
Neon Therapeutics, Inc. NTGN Officer filed 2018–2018
Myokardia, Inc. MYOK Director filed 2015–2018
Allena Pharmaceuticals, Inc. ALNA Officer filed 2017–2017
Cytomx Therapeutics, Inc. CTMX Officer filed 2015–2017
Global Blood Therapeutics, Inc. GBT Director filed 2015–2017
Alnylam Pharmaceuticals, INC. ALNY Director filed 2006–2017
Blueprint Medicines Corp BPMC Officer filed 2015–2017
Editas Medicine, Inc. EDIT Officer filed 2016–2016
Zafgen, INC. ZFGN Director filed 2014–2015
Foundation Medicine, Inc. FMI Officer filed 2015–2015
Agios Pharmaceuticals, INC. AGIO Director filed 2013–2015
Sesen Bio, Inc. SESN Officer filed 2014–2014
Human Genome Sciences INC HGSI Director filed 2006–2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.